• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Recombinant duck enteritis virus expressing the HA gene from goose H5 subtype avian influenza virus

tetano

Editor, Senior Moderator
Vaccine. 2013 Oct 18. pii: S0264-410X(13)01411-4. doi: 10.1016/j.vaccine.2013.10.035. [Epub ahead of print]
Recombinant duck enteritis virus expressing the HA gene from goose H5 subtype avian influenza virus.
Liu X, Wei S, Liu Y, Fu P, Gao M, Mu X, Liu H, Xing M, Ma B, Wang J.
Source

College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, China.
Abstract

The duck enteritis virus (DEV) may be a promising candidate viral vector for an aquatic poultry vaccination that can protect against multiple pathogens because it has a very large genome and a narrow host range. Recently, we described two DEV recombinants that contained deletions of the viral US2 or gIgE genes. The hemagglutinin (HA) gene of an H5N1-type highly pathogenic avian influenza virus (HPAIV) of goose origin was inserted into the deletion sites to construct two rDEVs expressing the AIV HA antigen. The resulting rDEV-ΔgIgE-HA or rDEV-ΔUS2-HA recombinant DEV viruses were used to infect duck embryo fibroblasts. Reverse transcription PCR, immunofluorescence and western blot analysis results indicated that rDEV-ΔgIgE-HA and rDEV-ΔUS2-HA were successfully expressed in duck embryo fibroblasts (DEFs). To investigate whether the HA gene could be stably maintained in the recombinant viruses, the viruses were passaged in DEFs 18 times. The HA gene in both recombinants could be detected by PCR amplification. The immunized four-week-old ducks induced specific antibodies against DEV and AIV HA and were protected against challenge infections with DEV AV1221 viruses.

Copyright ? 2013. Published by Elsevier Ltd.
KEYWORDS:

CEF, CPE, DEF, DEV, Duck enteritis virus (DEV), Goose origin, H5N1 avian influenza virus (AIV), HA, HPAIV, Hemagglutinin (HA), US, chicken embryo fibroblast, cytopathic effects, duck embryo fibroblast, duck enteritis virus, gE, gEBn, gEBw, gI, glycoprotein E, glycoprotein I, hemagglutinin, highly pathogenic avian influenza virus, post-vaccination, pv, rDEV, recombinant DEV, the extracellular region of gE gene, the intracellular region of gE gene, unique short, wild type DEV, wtDEV

PMID:
24144474
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24144474
 
Back
Top Bottom